Al-Samkari, H., Galacteros, F., Glenthoj, A., Rothman, J. A., Andres, O., Grace, R. F., … van Beers, E. J. (2021). ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused. In ONCOLOGY RESEARCH AND TREATMENT (Vol. 44, pp. 40–40).

Al-Samkari, H., F. Galacteros, A. Glenthoj, J. A. Rothman, O. Andres, R. F. Grace, Morado M. Arias, et al. “ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused.” In ONCOLOGY RESEARCH AND TREATMENT, 44:40–40, 2021.

Al-Samkari H, Galacteros F, Glenthoj A, Rothman JA, Andres O, Grace RF, et al. ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused. In: ONCOLOGY RESEARCH AND TREATMENT. 2021. p. 40–40.

Al-Samkari, H., et al. “ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused.” ONCOLOGY RESEARCH AND TREATMENT, vol. 44, 2021, pp. 40–40.

Al-Samkari H, Galacteros F, Glenthoj A, Rothman JA, Andres O, Grace RF, Arias MM, Layton DM, Onodera K, Verhovsek M, Barcellini W, Judge MP, Beynon V, Xu E, Hawkins P, Zagadailov E, Gheuens S, van Beers EJ. ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused. ONCOLOGY RESEARCH AND TREATMENT. 2021. p. 40–40.